News
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
The World from PRX on MSN3h
PEPFAR and the future of the global fight against HIVPEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...
MedPage Today on MSN20h
Switching ART Regimens Didn't Lead to Weight Loss in Patients With HIV and ObesityA dults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer ...
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
3don MSN
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
In his rescissions request to Congress last month, President Donald Trump asked that the hundreds of millions dollars budgeted for the President's Emergency Plans for AIDS Relief, or PEPFAR, be ...
News-Medical.Net on MSN21h
Many HIV-exposed newborns miss preventive treatment after birthNewborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
The WHO has approved the use of a new drug to prevent HIV. The drug is called Lenacapavir, and what makes it unique is that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback